Related Experiment Video

Updated: Sep 21, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Epidermal growth factor-related peptides as targets for experimental therapy of human colon carcinoma

N Normanno1, A De Luca, D S Salomon

  • 1Oncologia Sperimentale D, ITN-Fondazione Pascale, Naples, Italy.

Cancer Detection and Prevention
|February 18, 1998
PubMed

Insights

Novel therapies targeting epidermal growth factor (EGF)-related peptides are needed for advanced colon cancer. Inhibiting these growth factors, like transforming growth factor-alpha (TGF-alpha), amphi-regulin (AR), and CRIPTO (CR), shows promise in slowing colon cancer growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Colorectal carcinomas exhibit limited sensitivity to traditional chemotherapy.
  • Advanced-stage colon cancer necessitates innovative therapeutic strategies for improved patient outcomes.
  • Growth factors significantly influence colon carcinoma cell proliferation.

Purpose of the Study:

  • To review recent findings on epidermal growth factor (EGF)-related peptides as potential therapeutic targets in colon cancer.
  • To explore the role of autocrine growth factors in colon carcinoma progression.
  • To assess the efficacy of targeting EGF-like growth factors and their receptors in experimental colon cancer therapy.

Main Methods:

  • Review of recent scientific literature on EGF-related peptides in colon cancer.
  • Analysis of studies utilizing antisense (AS) retroviral expression vectors and AS oligonucleotides.
  • Investigation of the impact of targeting TGF-alpha, AR, and CR on colon carcinoma cell lines.

Main Results:

  • Transforming growth factor-alpha (TGF-alpha), amphi-regulin (AR), and CRIPTO (CR) are frequently overexpressed in human colon carcinomas.
  • These EGF-related peptides function as autocrine growth factors in colon carcinoma cells.
  • Antisense strategies targeting TGF-alpha, AR, or CR inhibit the growth and transformation of colon carcinoma cell lines.

Conclusions:

  • EGF-like growth factors and their receptors represent promising targets for experimental colon cancer therapy.
  • Targeting autocrine growth factor signaling offers a potential strategy to overcome chemoresistance in colorectal carcinomas.
  • Further research into these pathways could lead to novel treatments for advanced colon cancer.

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...